Hotpennystocknews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angeles, CA -- (SBWIRE) -- 01/28/2014 -- Hotpennystocknews.com issues special report on - International Stem Cell Corporation (ISCO),Therapy Cells Inc (OTCMKTS:TCEL),Vitro Diagnostics, Inc. (OTCMKTS:VODG),HEMP, INC. (OTCMKTS:HEMP)
International Stem Cell Corporation (ISCO) is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of biomedical products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos.
ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCellTM. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care.
ISCO settled up at $0.229 on below-normal volume of 346,900.00 shares during the recent trading session. The stock has its 12-month range $ 0.13 - 0.41. It is trading in a range of $ 0.22 - 0.23 today.
Can ISCO Show a Strong Recovery? Find out in This Research Report.
Therapy Cells Inc (OTCMKTS:TCEL) holds patents on the process of multiplying Mature Adult Cells for the repair of parts of the body which have been damaged by trauma or disease. They are currently in the final stages of testing their product before applying for approvals for clinical use.
Keep a close eye on TCEL, as the stock has been showing unusual moves over the past weeks. At Current market price, TCEL has recovered +285.71% from its 52-week Low of 0.0007 and has Pulled back -99.47% from its 52-week high of 0.51.
You can view the full analysis from the report here.
Vitro Diagnostics, Inc. (OTCMKTS:VODG) is focused on development, manufacturing and distribution of stem cell products and related tools for use in research and drug discovery. The Company develops, manufactures and markets products for use in research and related applications. The Company’s stem cell technology includes cell lines, supporting products and methods for generation and differentiation of stem cells into products with application to treatment of numerous diseases such as heart disease, stroke, Parkinson’s and Alzheimer’s disease.
During the fiscal year ended October 31, 2011 (fiscal 2011), the Company focused on commercialization of a series of products targeting global markets in stem cell research, including products needed by scientists engaged in stem cell research.
Shares of VODG is +0.029 - +52.73% from the previous close of $0.055. It traded between $0.055 - 0.084 with total traded volume of 273850 shares. At Current Market Price, VODG is in distance of +69.02% from its 50-day Moving Average price of $0.0497 and +65.34% from its 200-day Moving Average price of $0.0508.
Is Investor Showing Any Interest On VODG? Find Out Here.
HEMP, INC. (OTCMKTS:HEMP) is in the business of research and development of all things made of industrial hemp. From clothing to nutraceuticals. These products are used all over America every day and are sold in the largest and most respected stores.
Industrial hemp is used for making fabric, paper, insulation, and plastics. It's seeds are consumed for the high protein level and omega fatty acids. Hemp oil is used for cooking and in salad dressings.
Hemp should not be confused with marijuana which is illegal and contains psychoactive ingredients. Hemp does not contain psychoactive compounds and is legal in the United States and most of the world.
HEMP ended higher24.60 % and complete the day at $0.0709. After opening at $0.06, the stock hit as high as $0.07. However, it traded between $0.01 and $0.15 over the last twelve months.
For Hot Stories, Daily News Of HEMP, Free Sign Up Here.
Neither Hotpennystocknews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by Hotpennystocknews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.Hotpennystocknews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Hotpennystocknews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in.
Read Full disclaimer at:http://www.hotpennystocknews.com/disclaimer.php
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)